The new antiepileptic drug levetiracetam (LEV, Keppra) was evaluated in a putative animal model for mania, namely, dexamphetamine-chlordiazepoxide mixture-induced hyperactivity in rats submitted to a Y-shaped maze test. Lithium chloride, sodium valproate, and carbamazepine, all clinically effective drugs in the treatment of acute mania, were used as comparators. The results indicate that the clinical references significantly attenuated the mixture-induced hyperactivity, thus confirming the sensitivity and pharmacological validity of this model. LEV also significantly attenuated the mixture-induced hyperactivity at doses within the range of those reported to be active in epilepsy models. ucb L060, the R-enantiomer of LEV, was without effect, thus indicating that the "antimanic" activity of LEV is stereospecific. These results suggest a potential for LEV in the treatment of mania and possibly in the management of bipolar disorder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/ebeh.2001.0254 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of the New Antiepileptic Drug Levetiracetam in an Animal Model of Mania.
Epilepsy Behav
October 2001
UCB S.A. Pharma Sector, Preclinical CNS Research, Chemin du Foriest, B-1420, Braine l'Alleud, Belgium
The new antiepileptic drug levetiracetam (LEV, Keppra) was evaluated in a putative animal model for mania, namely, dexamphetamine-chlordiazepoxide mixture-induced hyperactivity in rats submitted to a Y-shaped maze test. Lithium chloride, sodium valproate, and carbamazepine, all clinically effective drugs in the treatment of acute mania, were used as comparators. The results indicate that the clinical references significantly attenuated the mixture-induced hyperactivity, thus confirming the sensitivity and pharmacological validity of this model.
View Article and Find Full Text PDFMagnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents.
Eur J Pharmacol
June 1993
Department of Pharmacology, Hunan Institute of Pharmaceutical Industry, Changsha, People's Republic of China.
A mixture of dexamphetamine and chlordiazepoxide induces hyperactivity in both mice and rats. This type of hyperactivity has been proposed as an animal model of mania. Magnesium valproate itself had little influence on the activity of normal mice and rats.
View Article and Find Full Text PDFInhibition by antimanic drugs of hyperactivity induced by methamphetamine-chlordiazepoxide mixture in mice.
Pharmacol Biochem Behav
April 1990
Department of Pharmacology, Okayama University Medical School, Japan.
The effects of lithium chloride and other antimanic drugs on locomotor hyperactivity induced by a mixture of methamphetamine (MAMP) and chlordiazepoxide (CDZP) were examined in mice, using an Animex activity meter. CDZP (12.5 mg/kg) given SC in combination with MAMP (1 mg/kg) caused a marked increase in locomotor activity, as compared with that in mice treated with MAMP alone.
View Article and Find Full Text PDFDexamphetamine (DEX) and chlordiazepoxide (CDZP) given together as mixtures have previously been shown to induce a characteristic "compulsive" form of locomotor hyperactivity in rats placed in unfamiliar environments, which was much greater than activity obtained with any dose of either drug given separately; acute pretreatment with lithium counteracted mixture-induced hyperactivity. The role of dopamine in these effects was investigated by measuring concurrently the levels of dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striatum. DEX (0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!